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Summary
In addition to traditional and novel experimental
approaches to study host–pathogen interactions,
mathematical and computer modelling have
recently been applied to address open questions in
this area. These modelling tools not only offer an
additional avenue for exploring disease dynamics
at multiple biological scales, but also complement
and extend knowledge gained via experimental
tools. In this review, we outline four examples
where modelling has complemented current experi-
mental techniques in a way that can or has already
pushed our knowledge of host–pathogen dynamics
forward. Two of the modelling approaches pre-
sented go hand in hand with articles in this issue
exploring fluorescence resonance energy transfer
and two-photon intravital microscopy. Two others
explore virtual or ‘in silico’deletion and depletion as
well as a new method to understand and guide
studies in genetic epidemiology. In each of these
examples, the complementary nature of modelling
and experiment is discussed. We further note that
multi-scale modelling may allow us to integrate
information across length (molecular, cellular,
tissue, organism, population) and time (e.g.
seconds to lifetimes). In sum, when combined,
these compatible approaches offer new opportuni-
ties for understanding host–pathogen interactions.
Introduction
Experimental science has generated tremendous insights
into host–pathogen interactions. Mathematical and com-
putational modelling (here, simply ‘modelling’) offers a
powerful and complementary tool for the study of host–
pathogen interactions. Like any experimental tool, it can
be used in combination with other approaches to offer
new insights into biological systems.
Models can be used to describe, simulate, analyse and
predict the behaviour of biological systems (Table 1). By
turning what is known about the biology into equations
and/or rules, you offer a framework by which to describe
and ultimately understand a system. For example, what
are the most important processes occurring, and what
may determine the rates of those processes? Answering
these questions, which typically involves incorporating
detail from many sources, can bring key hypotheses and
assumptions to light. Note that we focus here on mecha-
nistic models (as opposed to empirical models, which
approximate the shape of a relationship without any
mechanistic basis, or statistical models). One can simu-
late the behaviour of a biological system by performing
in silico experiments, that is, numerically solving the
equations/rules that describe the model. Does the model
reproduce the known behaviour of molecules, cells or
organisms of interest? The results of such in silico experi-
ments become the input for further analysis, for example,
identification of key parameters or mechanisms, interpre-
tation of data, or comparison of the ability of different
mechanisms to generate observed data. Finally, a model
that successfully describes existing experimental data
may be used to predict the result of new experiments
and generate further hypotheses about a system. For
example, novel therapeutics can be tested first via a
virtual clinical trial.
A quick history of modelling in host–pathogen
interactions
Modelling has an extensive history in the study of host–
pathogen interactions. Models dating as far back as 1760
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explored the epidemiology of smallpox, malaria and
cholera (Farr, 1866; Ross, 1916; Kermack and McKen-
drick, 1927; Dietz and Heesterbeek, 2000), attempting to
clarify the dynamics of epidemics and how disease is
spread. More recent epidemiological models explore the
dynamics of susceptible, infected and recovered popula-
tions of individuals for many diseases and have been
instrumental in shaping public health policy (Young and
Dye, 2006). Focusing at the level of an individual, models
were developed to understand various aspects of the
immune system in the absence of infection, for example,
generation of antibody diversity, T cell homeostasis and
cytokine dynamics (Segel, 1984; Perelson, 1989; Nowak
and May, 2000; Segel and Cohen, 2001; Yates et al.,
2004). The first generation of models to explicitly include
a pathogen at the level of the immune system contributed
to our understanding of infection with HIV, Mycobacterium
tuberculosis and Leukemia cytomegalovirus (Perelson,
1999; Wigginton and Kirschner, 2001; Ganusov and Antia,
2005). Most recently, detail about signalling pathways is
being incorporated into both immune cell and host–
pathogen models, with the potential of identifying new
drug targets (Goldstein et al., 2004; Kinzer-Ursem et al.,
2006; Kemp et al., 2007; Franke et al., 2008). Collectively,
these models cover spatial scales that range from
molecular to cellular to tissue to organism to population
and time scales that range from seconds to lifetimes.
In this article, we focus on how modelling can comple-
ment experimental tools that are currently being applied
to understand host–pathogen interactions. Two other
articles in this issue focus on new techniques, intravital
multiphoton microscopy (MPM) and four-dimensional
(three dimensions in space and one dimension in time)
FRET (fluorescence resonance energy transfer), which
offer exciting first-time visual data on spatial aspects of
host–pathogen interactions in tissues. The first two of our
four examples focus on insights gained when modelling is
paired with these techniques. The second two examples
we offer are additional modelling approaches that com-
plement other techniques in host–pathogen interaction
studies.
Example 1: modelling approaches to complement
intravital MPM
Until recently, lymph nodes and other immune sites in the
body have been difficult to study in vivo. The recent devel-
opment of imaging techniques such as intravital MPM has
allowed novel observations of cellular dynamics. In this
issue, Miller and colleagues present details regarding
MPM and its role in studying host–pathogen interactions
(Konjufca and Miller, 2009).
Multiphoton microscopy has provided useful insights
into aspects of immune cell interactions in the lymph node
(LN), liver and gut. However, MPM is limited to examina-
tion of only a portion of a single tissue and for typically
only a few minutes. In the study of LNs, for example, the
dynamics of dendritic cell (DC)–T cell interaction have
been explored in a ~100 mm ¥ 100 mm window to produce
movies that last a few minutes, although DCs and T cells
are likely present in LNs for hours to days (Miller et al.,
2002; 2004a; von Andrian and Mempel, 2003; Catron
et al., 2004). To obtain statistical significance, many cell
paths and behaviours are needed, yet typically MPM
experiments are able to track only a handful of cells. In
addition, although observations are made of single cell
behaviour, the mechanisms driving that behaviour are not
directly measurable. Finally, experimental preparations
are often modified to increase the opportunity for captur-
ing cellular dynamics. For example, many studies of cells
in the LN increase the density of cognate T cells or DCs
beyond the physiological range in order to facilitate obser-
vation and get statistical significance (Miller et al., 2004b;
Celli et al., 2008).
Models of cell motion have recently been developed.
These aim first to replicate observed cell paths in MPM
studies and then to predict cell motion over larger areas
and longer times and ultimately to understand any impli-
cations for immunology [another approach would be to
develop algorithms to analyse the large amounts of data
generated from MPM studies (Witt et al., 2005)]. For
example, movement of T cells within a LN was studied
(Beltman et al., 2007). Using a small-scale (20 mm)
spatio-temporal mathematical model of T cell and DC
migration in LN, the sometimes erratic movement of T
cells observed with MPM was predicted to be due to
the densely packed cellular environment and not some
Table 1. Functions of a mathematical/computational model.
Describe
Provide a framework for understanding an experimental
system
Clarify hypotheses and assumptions
Consolidate information from many sources
Simulate
Perform in silico experiments, including
virtual knockouts and deletions
long-time runs (e.g. months to years)
Analyse
Compare different theories or proposed mechanisms
Generate hypotheses
Identify key parameters, molecules, mechanisms or
pathways
Study dynamic aspects
Interpret existing experimental data
Identify new biological mechanisms
Predict
Motivate new experiments
Suggest new therapies or vaccine targets
Predict how interventions at one scale would affect
another
Offer new explanations for existing data
Virtual interventions (e.g. pharmaceuticals)
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inherent motility property of T cells. Their experimental
colleagues used MPM to confirm these results.
Encounters between T cells and antigen-presenting
cells (APCs) can be observed via MPM and lead to T cell
activation. How long does it take for an antigen-specific T
cell to find its cognate APC ‘match’ in the LN? Two recent
models explore this question using different modelling
approaches to describe and make predictions based on
MPM data. Preston et al. (2006) use asymptotic methods
to calculate the time required for a randomly moving T cell
to encounter a stationary DC and the threshold level of
APCs required for a T cell to have > 50% probability of
finding an APC within 24 h. In our work, in contrast, we
use an agent-based model (ABM) approach that includes
detailed representations of individual CD4+ and CD8+ T
cells and DCs in various stages of activation that are
present in the LN (Fig. 1). Using this model, we generate
individual cell tracks for validation with MPM data from our
experimental collaborator Mark Miller and his group
(Riggs et al., 2008). A prediction of the ABM model is that
Fig. 1. Shown is a grid that represents the paracortoid region of a lymph node (or T cell zone). The grid is subdivided into 20 micron by
20 micron compartments that can hold up to one DC (MDC – mature, LDC-licensed) or up to two T cells (either CD4+ or CD8+ T cells, which
are r, resting; a, activated; or e, effector). While DCs exist within one compartment, their influence represents a sweep area that extends to
the surrounding compartments around the DC allowing any T cell that comes into those spaces to interact with a DC. T cells enter the LN
through the afferent lymphatic ducts (AL) and leave via the efferent lymphatic (EF). DCs enter via high endothelial venules (HEV). Shown are
enlargements of regions indicating the existence of these complexities on the grid. A computer model solves the rules described for cells
interacting on this grid and the output can be visualized as a time-lapse simulation (see http://malthus.micro.med.umich.edu/lab/movies/
LNtzone/).
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T cell–DC contact begins less than 30 min after cells enter
the LN, with an average time for a T cell to find its APC
match of several hours.
In addition, we used our ABM to question whether
chemotaxis, rather than random motion alone, plays a
role in aiding antigen-specific CD4+ T cells in finding their
cognate DC within a LN (Riggs et al., 2008). While
chemotaxis does increase total number of T cell–DC con-
tacts, it also decreases the number of unique contacts,
ultimately leading to the production of fewer activated T
cells than a random search strategy. In contrast, other
cells in the immune system certainly use chemotaxis:
neutrophil chemotaxis is well documented and recent
experiments suggest that CD8+ T cells in the LN use a
chemotactic mechanism (Castellino et al., 2006).
Most recently, we have explored the relationship
between cognate T cell frequency and the density of
antigen-bearing DCs present in the LN (T. Riggs, M.
Pande, J.J. Linderman, and D.E. Kirschner, in prepara-
tion). Understanding how cognate frequency affects T cell
activation will be important in interpreting MPM studies
that use cognate frequencies elevated above physiologi-
cal levels. Both T cell frequency and DC density increase
the output of primed T cells.
Example 2: modelling approaches to complement
FRET microscopy
Protein–protein interaction networks form the backbone of
signalling pathways and constitute a fundamental regula-
tory mechanism controlling the behaviour of living
cells. Until recently, pathway analysis has relied largely
on biochemical means (e.g. coimmunoprecipitation,
mass-spectroscopy, yeast two-hybrid) to define protein
interactions. These measurements provide little dynamic
or quantitative information about protein interactions and
effectively no information about the subcellular organiza-
tion of a pathway. As described elsewhere in this issue
(Hoppe et al., 2009), microscopy techniques are now
being used to investigate the signalling pathways acti-
vated during infection. In particular, FRET microscopy can
be used to ascertain the binding of specific protein pairs
inside live cells by fluorescently labelling them with differ-
ent variants of fluorescent proteins. The range over which
FRET can occur is less than 10 nm and thus the appear-
ance of FRET suggests the association of donor- and
acceptor-labelled proteins (Kenworthy, 2001). While quali-
tative information on protein–protein interactions has
been routinely inferred from FRET image data, methods
for quantitative characterization of such interactions from
these data have proved more difficult to develop and
implement.
As a starting point in the quantitative analysis of FRET
images, computational methods for image deconvolution
(correcting for optical blurring inherent in any imaging
process) and spectral unmixing of image data are
required and calibration data are needed (Wu and Pollard,
2005; Hoppe et al., 2008). Next one needs methods to
extract quantitative pathway information from these cor-
rected FRET images of protein–protein interactions. In
general, information on the location of individual proteins
and of various protein–protein complexes as a function of
time might be used to extract values for both equilibrium
and rate parameters describing protein–protein binding
and protein movement. To do this, models could be devel-
oped to describe probable events occurring in cells and
then, by comparison with image data, to extract or infer
corresponding parameter values.
We recently described one such effort to obtain the
in vivo value of the protein–protein binding equilibrium
dissociation constant (Kd) in small volume elements of the
cell (voxels) (K. Mehta et al., submitted) (Voxels are
simply the three-dimensional equivalent of a pixel).
Labelled acceptor (A*) and labelled donor (D*) proteins,
each tagged with appropriate fluorescent proteins, as
assumed to react according to
A* D* A*D*+ ← →⎯⎯Kd
where A*D* is the acceptor–donor complex. At the same
time, endogenous (unlabelled) forms of A and D also exist
and are assumed capable of binding with labelled or unla-
belled species. Application of the equations describing
this simple model to images allowed us to infer values of
Kd; one can also infer different values of Kd in different
cellular regions (Fig. 2A).
These methods, while still in their infancy, can poten-
tially be applied to study any protein–protein binding
interactions. The modelling and analysis may also be
extended to analyse image data over time to allow infer-
ence of kinetic parameters. Ultimately, obtaining rate
and/or equilibrium parameters describing protein–protein
interactions may aid not only in signalling pathway recon-
struction, including pathways activated during the early
stages of infection, but also in understanding how drugs,
inhibitors or pathogens might alter those pathways. In
addition, we note that terabytes of image data will ulti-
mately be produced as FRET imaging is performed with
high three-dimensional resolution over time in living cells,
far outstripping human capacity to interpret, digest or
analyse. Methods of data reduction and abstraction,
including inference of equilibrium and/or kinetic para-
meters, will be critical to our ability to utilize these data.
Example 3: modelling approaches to complement
epidemiological association studies
In the epidemiological literature, genetic polymorphisms
are often observed to be associated with disease
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susceptibility, but inconsistently so. In addition to experi-
mental concerns [e.g. small sample size (Alcais et al.,
2001)], there is the very real possibility that multiple poly-
morphisms simultaneously affect disease susceptibility.
For instance, a polymorphism in gene A, A1, may render
the human host more susceptible to disease in the pres-
ence of one polymorphism in gene B, B1, but not in the
presence of another polymorphism in B, B2. Such com-
plications could underlie the difficulty in interpreting
results of association studies, which certainly fail to assay
all polymorphisms and in fact often assay only a single
polymorphism. For example, both particular IFN-g and
major histocompatibility complex class II (MHCII)1 alleles
have each individually been associated with tuberculosis
(TB) susceptibility (Teran-Escandon et al., 1999; Lio et al.,
2002), but not in all populations. Both genes are relevant
to the antigen presentation pathway, a crucial pathway in
the development and maintenance of an effective and
sustained immune response.
Modelling can play a role in elucidating how multiple
factors can simultaneously affect disease outcome and
can identify pairs or sets of factors (as represented by
parameters in a model) that can compensate for each
other. We recently developed an ordinary differential
equation model of the events in antigen presentation
(Chang et al., 2005; 2008). Our model includes a repre-
sentation of processes occurring in the APC (peptide–
MHCII binding and trafficking and presentation of
peptide–MHCII complexes), interaction between an APC
and a T cell, and a T cell activation response (cytokine
production). This yields a multi-scale model that links
molecular and intracellular events to cellular and multi-
cellular outcomes.
One key parameter in the model is the equilibrium
binding affinity (Kd) of peptide for MHCII. Experimental
measurements of Kd are available for some peptides
and MHCII (AntiJen database; http://www.jenner.ac.uk/
antijen; Blythe et al., 2002) and Immune Epitope Data-
base and Analysis Resource (Peters et al., 2005; http://
www.immuneepitope.org/home.do). However, given the
plethora of possible peptides (~1011) and the large number
of MHCII variants (several thousand), experimental mea-
surements for all combinations are unlikely. Algorithms
are available and under development that allow for pre-
dictions of binding affinities (Chang et al., 2006; Nielsen
1We use MHCII for consistency, but in humans this gene is
termed HLA.
Fig. 2. A. Schematic of a cell that has been loaded with acceptor (yellow)- and donor (blue)-labelled proteins to achieve FRET. Analysis of
FRET images can be used to obtain values of the equilibrium dissociation constant (Kd). Note that one obtains a probability distribution rather
than a whole-cell averaged value, potentially allowing identification of multiple distinct values of Kd in different cellular regions.
B. Trade-offs during antigen presentation. In the top plot, we show the values of peptide–MHCII affinity and IFN-g concentration that give the
same response, that is, T cell receptor internalization or T cell cytokine secretion. Within the middle portion of the curve, a deficiency in one
parameter can compensate for a change in the other parameter; at the ends of the curve peptide–MHC affinity is dominant. In the lower plot,
we show values of the number of peptide–MHCII complexes on a DC and the number of DCs in the LN that give the same number of
activated CD4+ T cells leaving the LN. Again, changes in one parameter are observed to compensate for changes in the other.
C. Virtual manipulation of CD8+ T cells during infection with M. tuberculosis. Solid curves show the wild-type response similar to that observed
in experiments, dashed curves show an alternative simulation. Top panel: CD8+ CTL T numbers grows slowly, peaking after day 150, and then
decay (solid curve), while the CD8+ IFN-g-producing T cells don not appear until day 200 (not shown). In our in silico alternative simulation,
we switch the order of the differential expression: CD8+ IFN-g-producing T cells emerge first and slowly decay over time (not shown) while the
CD8+ CTL T cells do not appear until day 200 and then slowly decay (dashed curve). Bottom panel, in the wild-type scenario, bacterial load is
large, and even oscillating (solid curve), but in the artificial scenario, the bacterial load is cleared (dashed curve).
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et al., 2008). Other parameters in the model include the
level of IFN-g expression by T cells, and the level of MHCII
expression by APCs.
Once validated against experimental data, our model
was used to explore whether one factor could compen-
sate for another, which we term a trade-off. Polymor-
phisms need not affect the same cell or even the same
space or time scale to be compensatory. For example,
considering that IFN-g upregulates MHCII expression,
could an allele of IFN-g sufficiently increase the number of
MHCII molecules per APC to offset deficiencies exhibited
by some MHCII alleles in binding epitopes from M. tuber-
culosis? Within certain ranges of IFN-g concentration
and peptide–MHCII affinity, the answer is yes (Fig. 2B).
However, in other ranges, polymorphisms in MHCII may
mask the effect of polymorphisms in IFN-g; that is, the
peptide–MHCII binding affinity is dominant. This trade-off
could account for inconsistencies in epidemiological
studies that attempted to link IFN-g polymorphisms and
TB susceptibility (Moran et al., 2007). We also found that
MHCII expression and MHCII binding polymorphisms,
antigen processing ability and MHCII binding poly-
morphisms, and peptide–MHCII affinity and affinity of
peptide–MHCII complexes for T cell receptors can be
compensatory.
In ongoing work, we also find such compensatory rela-
tionships in the LN using our ABM based on MPM data
discussed under Example 1 (T. Riggs, M. Pande, J.J.
Linderman, and D.E. Kirschner, in preparation). For
example, an increase in the number of peptide–MHC
complexes on a DC surface can in some circumstances
compensate for a decrease in the number of antigen-
bearing DCs present, trading off to yield the same number
of, say, primed T cells (Fig. 2B). This hints at the complex-
ity that may be influenced by pathogens that can alter
antigen processing leading to suppressed immunity
(Chang et al., 2005). In the future, one might use these
models to rank polymorphisms by effect, providing a new
tool for designing epidemiological association studies.
Example 4: modelling approaches to complement
genetic deletion and molecular depletion studies
The use of genetic knockouts and molecular depletion
studies for understanding cells and effector molecules
has been of tremendous benefit to immunology. It has
allowed the analysis of specific roles played by individual
genes and molecules in the pathogenesis of many infec-
tious diseases. For example, depletion of macrophages in
a murine model of anthrax helped to underscore their
importance in disease progression (Hanna et al., 1993).
Depletion (or neutralization) of the cytokine IL-17 was
shown to be a necessary factor in development of
acquired immunity to Streptococcus pneumoniae (Lu
et al., 2008). Humans with the mutation CCR5D32 are
missing the chemokine receptor CCR5 and are protected
from HIV-1 infection (Sullivan et al., 2001). As a final
example, patients with latent TB who are treated with
anti-tumour necrosis factor (TNF) drugs for their rheuma-
toid arthritis suffer reactive TB, suggesting that TNF plays
a major role in containing infection (Wallis et al., 2004). In
other cases, deletions and depletions provide less infor-
mative or even ambiguous results. Still further, there are
many deletions and depletions that cannot be performed
because of lack of availability of animals with that pheno-
type or lack of reagents to perform neutralization or deple-
tion studies.
Modelling can be used in both experimentally acces-
sible and inaccessible cases to contribute to our
understanding of the roles of particular molecules in
immunology. It is possible to perform both virtual (in silico)
deletion and depletion experiments (cf. Yates et al.,
2000). Virtual deletion experiments mimic knockouts by
removing a molecule or cell type at day 0, before infection
is introduced. In virtual depletion experiments the relevant
molecule or cell concentrations are set to zero at any time
post infection.
For example, we used a model to make predictions on
the role of CD8+ T cells in the host–pathogen interaction
with M. tuberculosis (Sud et al., 2006). The immune
response to M. tuberculosis is cell-mediated and results in
the formation of granuloma in the lungs. These are col-
lections of cells and cytokines all aimed at physically
containing and immunologically restraining bacteria. Data
suggested that there are two subsets of effector CD8+ T
cells: those that produce cytokines including IFN-g and
TNF, and those that produce perforin/granzyme and
perform CTL activity (Lazarevic et al., 2005). These cells
were observed to be differentially expressed during
disease progression. It is presently impossible to delete or
deplete these specific subsets of effector CD8+ T cells.
We developed an ordinary differential equation model that
represented these CD8+ T cell subtypes in a larger model
of the immune response to M. tuberculosis and performed
virtual deletion and depletion studies (Sud et al., 2006).
We first either deleted or depleted (done during latency)
each of the cell types individually. When the INF-g-
producing CD8+ T cell population was depleted or
deleted, the latency state achieved was similar to wild
type. When the CTL-CD8+ T cell population was depleted
or deleted, latency was still achieved, but with a different
phenotype from wild type. Oscillations in bacterial load
were observed, a less stable latent state that is more
easily perturbed to active disease. Also, the bacterial
loads were higher in this latent scenario as compared with
wild type. Interestingly, we found that when both subsets
of CD8+ T cells were simultaneously deleted, a synergy
occurs and the system goes to active disease. These
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results suggest that both cell types are required for control
of infection, but each plays an independent role in affect-
ing that result.
In a related study, we used our model described above
to study the role of differential cell population dynamics in
TB disease progression. In mouse studies (and included
in the model), CTL-CD8+ T cells appear quickly in the first
20 days following infection and then slowly die off; INF-g-
producing CD8+ T cells appear about day 20 and then
increase for more than 6 months (Lazarevic et al., 2005).
We simulated a case in which the appearance and timing
of these cell populations was reversed, and found that the
bacterial infection could be cleared (Fig. 2C). This result
suggests that one reason individuals may have trouble
clearing M. tuberculosis infection is because they are pro-
ducing these different CD8+ T cells subclasses in the
wrong order. Treatment and vaccine studies aimed at
understanding this could be very powerful in combating
infection.
Conclusions and future directions
We believe that modelling, particularly in combination with
experimental studies, is a tool that has much to contribute
to the study of host–pathogen interactions. As described
above, a multitude of different modelling formalisms are
available and appropriate for different situations, similar to
experimental techniques.
Most models (and experiments also) focus on a single
length (and time) scale. It has become increasingly clear,
however, that events at different length and time scales all
simultaneously affect the overall outcome of biological
processes including host–pathogen interactions. For
example, the affinity of particular peptides for MHCII may
play a role in the efficacy of antigen presentation, affecting
the number of T cells generated which will dictate success
or failure of the immune response in a given situation
(Kirschner et al., 2007). Experiments that simultaneously
track molecular, cellular, tissue, organism and population
scale events over time are rare and difficult to perform
with accuracy. However, multi-scale models offer a dis-
tinct advantage in being able to integrate information
across scales. Multi-scale modelling requires building and
validating models at individual scales and linking them
together in a method that is computationally feasible
(Alarcon et al., 2004; Kirschner et al., 2007).
Ultimately, such multi-scale models may allow us to
predict how particular interventions at the molecular scale
will manifest themselves at higher scales. This under-
standing may guide the development of effective treat-
ments for an infected host or vaccines for entire
populations. Modelling is a tool that will allow these
next important steps in the study of host–pathogen
interactions.
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